Last reviewed · How we verify
Estradiol 2 MG
Estradiol 2 MG is a Small molecule drug developed by University Hospital, Angers. It is currently FDA-approved. Also known as: provames 2mg, Estrace.
At a glance
| Generic name | Estradiol 2 MG |
|---|---|
| Also known as | provames 2mg, Estrace |
| Sponsor | University Hospital, Angers |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese Patients (PHASE3)
- Efficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment (PHASE2)
- Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029) (PHASE2)
- Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency (PHASE3)
- Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (PHASE2)
- A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations (PHASE1, PHASE2)
- Artificial Cycle With or Without GnRH Agonist Pre-treatment for Frozen Embryo Transfer in Adenomyosis Patients (NA)
- Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Estradiol 2 MG CI brief — competitive landscape report
- Estradiol 2 MG updates RSS · CI watch RSS
- University Hospital, Angers portfolio CI
Frequently asked questions about Estradiol 2 MG
What is Estradiol 2 MG?
Estradiol 2 MG is a Small molecule drug developed by University Hospital, Angers.
Who makes Estradiol 2 MG?
Estradiol 2 MG is developed and marketed by University Hospital, Angers (see full University Hospital, Angers pipeline at /company/university-hospital-angers).
Is Estradiol 2 MG also known as anything else?
Estradiol 2 MG is also known as provames 2mg, Estrace.
What development phase is Estradiol 2 MG in?
Estradiol 2 MG is FDA-approved (marketed).
Related
- Manufacturer: University Hospital, Angers — full pipeline
- Also known as: provames 2mg, Estrace
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing